MEDPLUS HEALTH SERVICES
|
|
BOM : 543427     NSE : MEDPLUS     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : High [>50%] |
Mar 11,2025 |
Price(EOD): ₹ 704.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 8,429.27 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
MEDPLUS HEALTH SERVICES | -3.6% | -13.6% | 2.4% |
SUN PHARMACEUTICAL INDUSTRIES | 2.8% | -7.5% | 2.3% |
DIVIS LABORATORIES | -0.2% | -9.9% | 60.4% |
CIPLA | 4.4% | -0.6% | -1% |
TORRENT PHARMACEUTICALS | 4.8% | -2.9% | 15.4% |
DR REDDYS LABORATORIES | NA | -9.4% | -10.2% |
MANKIND PHARMA | -0.7% | -8.8% | 7.1% |
ZYDUS LIFESCIENCES | 2.5% | -11.4% | -5.5% |
LUPIN | 2.9% | -8.1% | 20.9% |
FUNDAMENTAL ANALYSIS OF MEDPLUS HEALTH SERVICES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF MEDPLUS HEALTH SERVICES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
63.63
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 132.47 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] 5.45
P/B Calculated based on Book Value of Rs 1,547.57 Cr
[Latest Year - Mar2024 - Consolidated Results ] 1.38
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 6,116.94 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
127% -17% -29% |
SHARE PRICE MOMENTUM OF MEDPLUS HEALTH SERVICES
MEDPLUS HEALTH SERVICES vs SENSEX
DEBT OF MEDPLUS HEALTH SERVICES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0 0 0 - |
0 0 0.1 0.03 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF MEDPLUS HEALTH SERVICES
Pledged Promoter Shares |
55.2 % | |
---|---|---|
As on : Dec2024 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF MEDPLUS HEALTH SERVICES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-0.93% 6.5% 18.45% 18.53% |
8.32% 44.39% 183.54% 234.7% |
QtrlyTrend |
6 | |
Latest Qtr: Dec2024 | ||
Quarterly Result Analysis → |
MEDPLUS HEALTH SERVICES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE 250 SMALLCAP INDEX | 2.3% | -11.5% | -5.4% |
BSE SMALLCAP | 2.3% | -12.2% | -1.9% |
BSE MIDSMALLCAP | 2.3% | -10.2% | -1.4% |
BSE 400 MIDSMALLCAP INDEX | 2.1% | -9.2% | -1% |
BSE ALLCAP | 2% | -7.2% | -1.1% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MICROCAP 250 | 4.9% | -12.3% | -0.3% |
NIFTY 500 EQUAL WEIGHT | 3.4% | -9.5% | NA |
NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | 2.4% | -8.8% | NA |
NIFTY MIDSMALL HEALTHCARE | 2.1% | -8.8% | 17.6% |
NIFTY TOTAL MARKET | 2% | -7.2% | -0.8% |
You may also like the below Video Courses
FAQ about MEDPLUS HEALTH SERVICES
Is MEDPLUS HEALTH SERVICES good for long term investment?
As on Mar 11,2025, the Fundamentals of MEDPLUS HEALTH SERVICES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of MEDPLUS HEALTH SERVICES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is MEDPLUS HEALTH SERVICES UnderValued or OverValued?
As on Mar 11,2025, MEDPLUS HEALTH SERVICES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of MEDPLUS HEALTH SERVICES ?
As on Mar 11,2025, the Intrinsic Value of MEDPLUS HEALTH SERVICES is Rs. 848.97 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 310.68
Fair Value [Median EV / Sales Model] : Rs. 848.97
Fair Value [Median Price / Sales Model] : Rs. 986.39
Estimated Median Fair Value of MEDPLUS HEALTH SERVICES : Rs. 848.97
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.